COCP - Cocrystal Pharma Inc
1.065
0.035 3.286%
Share volume: 55,046
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$1.03
0.03
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-14-2024 | 11-13-2024 | 05-15-2025 | 08-14-2025 | 11-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 4.158 M | 5.448 M | 5.042 M | 2.341 M | 2.108 M | 2.089 M | |
| Selling general and admin | 1.208 M | 1.140 M | 1.800 M | 981.000 K | 986.000 K | 1.135 M | |
| Research and development | 2.950 M | 4.308 M | 3.242 M | 1.360 M | 1.122 M | 954.000 K | |
| Total expenses | 4.158 M | 5.448 M | 5.042 M | 2.341 M | 2.108 M | 2.089 M | |
| 31.02% | -7.45% | -53.57% | -9.95% | -0.90% | |||
| Operating income | -4.158 M | -5.448 M | -5.042 M | -2.341 M | -2.108 M | -2.089 M | |
| Ebit | -4.176 M | -5.494 M | -5.050 M | -2.338 M | -2.083 M | -2.071 M | |
| Pretax income | -3.956 M | -5.343 M | -4.939 M | -2.301 M | -2.055 M | -2.049 M | |
| 35.06% | -7.56% | -53.41% | -10.69% | -0.29% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.956 M | -5.343 M | -4.939 M | -2.301 M | -2.055 M | -2.049 M | |
| -35.06% | 7.56% | 53.41% | 10.69% | 0.29% |